ICD-10-CM Code T80: Complications following infusion, transfusion and therapeutic injection and Related Diagnosis Codes.


The ICD-10-CM (the International Classification of Diseases, Tenth Revision, Clinical Modification) is a standardized coding system used when classifying diseases and medical conditions. Healthcare providers report these codes on Medical claims when diagnosing patient care.

Explore ICD-10-CM codes, organized by chapters based on body systems and medical conditions, as outlined in the International Classification of Diseases, Tenth Revision, Clinical Modification.

Tip: Have a specific ICD-10-CM code? Use our simple to use ICD-10-CM Code Lookup tool.

Eclaims - ICD-10-CM Tabular Code List v1.0.0

A categorized list of ICD-10-CM codes organized by chapters based on body systems or medical conditions, according to the International Classification of Diseases, Tenth Revision, Clinical Modification.

Questions
Results
  • T80 - Complications following infusion, transfusion and therapeutic injection
    • T80.0 - Air embolism following infusion, transfusion and therapeutic injection
      • T80.0XXA - Air embolism following infusion, transfusion and therapeutic injection, initial encounter
      • T80.0XXD - Air embolism following infusion, transfusion and therapeutic injection, subsequent encounter
      • T80.0XXS - Air embolism following infusion, transfusion and therapeutic injection, sequela
    • T80.1 - Vascular complications following infusion, transfusion and therapeutic injection
      • T80.1XXA - Vascular complications following infusion, transfusion and therapeutic injection, initial encounter
      • T80.1XXD - Vascular complications following infusion, transfusion and therapeutic injection, subsequent encounter
      • T80.1XXS - Vascular complications following infusion, transfusion and therapeutic injection, sequela
    • T80.2 - Infections following infusion, transfusion and therapeutic injection
      • T80.21 - Infection due to central venous catheter
        • T80.211 - Bloodstream infection due to central venous catheter
          • T80.211A - Bloodstream infection due to central venous catheter, initial encounter
          • T80.211D - Bloodstream infection due to central venous catheter, subsequent encounter
          • T80.211S - Bloodstream infection due to central venous catheter, sequela
        • T80.212 - Local infection due to central venous catheter
          • T80.212A - Local infection due to central venous catheter, initial encounter
          • T80.212D - Local infection due to central venous catheter, subsequent encounter
          • T80.212S - Local infection due to central venous catheter, sequela
        • T80.218 - Other infection due to central venous catheter
          • T80.218A - Other infection due to central venous catheter, initial encounter
          • T80.218D - Other infection due to central venous catheter, subsequent encounter
          • T80.218S - Other infection due to central venous catheter, sequela
        • T80.219 - Unspecified infection due to central venous catheter
          • T80.219A - Unspecified infection due to central venous catheter, initial encounter
          • T80.219D - Unspecified infection due to central venous catheter, subsequent encounter
          • T80.219S - Unspecified infection due to central venous catheter, sequela
      • T80.22 - Acute infection following transfusion, infusion, or injection of blood and blood products
        • T80.22XA - Acute infection following transfusion, infusion, or injection of blood and blood products, initial encounter
        • T80.22XD - Acute infection following transfusion, infusion, or injection of blood and blood products, subsequent encounter
        • T80.22XS - Acute infection following transfusion, infusion, or injection of blood and blood products, sequela
      • T80.29 - Infection following other infusion, transfusion and therapeutic injection
        • T80.29XA - Infection following other infusion, transfusion and therapeutic injection, initial encounter
        • T80.29XD - Infection following other infusion, transfusion and therapeutic injection, subsequent encounter
        • T80.29XS - Infection following other infusion, transfusion and therapeutic injection, sequela
    • T80.3 - ABO incompatibility reaction due to transfusion of blood or blood products
      • T80.30 - ABO incompatibility reaction due to transfusion of blood or blood products, unspecified
        • T80.30XA - ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter
        • T80.30XD - ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, subsequent encounter
        • T80.30XS - ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela
      • T80.31 - ABO incompatibility with hemolytic transfusion reaction
        • T80.310 - ABO incompatibility with acute hemolytic transfusion reaction
          • T80.310A - ABO incompatibility with acute hemolytic transfusion reaction, initial encounter
          • T80.310D - ABO incompatibility with acute hemolytic transfusion reaction, subsequent encounter
          • T80.310S - ABO incompatibility with acute hemolytic transfusion reaction, sequela
        • T80.311 - ABO incompatibility with delayed hemolytic transfusion reaction
          • T80.311A - ABO incompatibility with delayed hemolytic transfusion reaction, initial encounter
          • T80.311D - ABO incompatibility with delayed hemolytic transfusion reaction, subsequent encounter
          • T80.311S - ABO incompatibility with delayed hemolytic transfusion reaction, sequela
        • T80.319 - ABO incompatibility with hemolytic transfusion reaction, unspecified
          • T80.319A - ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter
          • T80.319D - ABO incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter
          • T80.319S - ABO incompatibility with hemolytic transfusion reaction, unspecified, sequela
      • T80.39 - Other ABO incompatibility reaction due to transfusion of blood or blood products
        • T80.39XA - Other ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter
        • T80.39XD - Other ABO incompatibility reaction due to transfusion of blood or blood products, subsequent encounter
        • T80.39XS - Other ABO incompatibility reaction due to transfusion of blood or blood products, sequela
    • T80.4 - Rh incompatibility reaction due to transfusion of blood or blood products
      • T80.40 - Rh incompatibility reaction due to transfusion of blood or blood products, unspecified
        • T80.40XA - Rh incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter
        • T80.40XD - Rh incompatibility reaction due to transfusion of blood or blood products, unspecified, subsequent encounter
        • T80.40XS - Rh incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela
      • T80.41 - Rh incompatibility with hemolytic transfusion reaction
        • T80.410 - Rh incompatibility with acute hemolytic transfusion reaction
          • T80.410A - Rh incompatibility with acute hemolytic transfusion reaction, initial encounter
          • T80.410D - Rh incompatibility with acute hemolytic transfusion reaction, subsequent encounter
          • T80.410S - Rh incompatibility with acute hemolytic transfusion reaction, sequela
        • T80.411 - Rh incompatibility with delayed hemolytic transfusion reaction
          • T80.411A - Rh incompatibility with delayed hemolytic transfusion reaction, initial encounter
          • T80.411D - Rh incompatibility with delayed hemolytic transfusion reaction, subsequent encounter
          • T80.411S - Rh incompatibility with delayed hemolytic transfusion reaction, sequela
        • T80.419 - Rh incompatibility with hemolytic transfusion reaction, unspecified
          • T80.419A - Rh incompatibility with hemolytic transfusion reaction, unspecified, initial encounter
          • T80.419D - Rh incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter
          • T80.419S - Rh incompatibility with hemolytic transfusion reaction, unspecified, sequela
      • T80.49 - Other Rh incompatibility reaction due to transfusion of blood or blood products
        • T80.49XA - Other Rh incompatibility reaction due to transfusion of blood or blood products, initial encounter
        • T80.49XD - Other Rh incompatibility reaction due to transfusion of blood or blood products, subsequent encounter
        • T80.49XS - Other Rh incompatibility reaction due to transfusion of blood or blood products, sequela
    • T80.A - Non-ABO incompatibility reaction due to transfusion of blood or blood products
      • T80.A0 - Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified
        • T80.A0XA - Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter
        • T80.A0XD - Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, subsequent encounter
        • T80.A0XS - Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela
      • T80.A1 - Non-ABO incompatibility with hemolytic transfusion reaction
        • T80.A10 - Non-ABO incompatibility with acute hemolytic transfusion reaction
          • T80.A10A - Non-ABO incompatibility with acute hemolytic transfusion reaction, initial encounter
          • T80.A10D - Non-ABO incompatibility with acute hemolytic transfusion reaction, subsequent encounter
          • T80.A10S - Non-ABO incompatibility with acute hemolytic transfusion reaction, sequela
        • T80.A11 - Non-ABO incompatibility with delayed hemolytic transfusion reaction
          • T80.A11A - Non-ABO incompatibility with delayed hemolytic transfusion reaction, initial encounter
          • T80.A11D - Non-ABO incompatibility with delayed hemolytic transfusion reaction, subsequent encounter
          • T80.A11S - Non-ABO incompatibility with delayed hemolytic transfusion reaction, sequela
        • T80.A19 - Non-ABO incompatibility with hemolytic transfusion reaction, unspecified
          • T80.A19A - Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, initial encounter
          • T80.A19D - Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter
          • T80.A19S - Non-ABO incompatibility with hemolytic transfusion reaction, unspecified, sequela
      • T80.A9 - Other non-ABO incompatibility reaction due to transfusion of blood or blood products
        • T80.A9XA - Other non-ABO incompatibility reaction due to transfusion of blood or blood products, initial encounter
        • T80.A9XD - Other non-ABO incompatibility reaction due to transfusion of blood or blood products, subsequent encounter
        • T80.A9XS - Other non-ABO incompatibility reaction due to transfusion of blood or blood products, sequela
    • T80.5 - Anaphylactic reaction due to serum
      • T80.51 - Anaphylactic reaction due to administration of blood and blood products
        • T80.51XA - Anaphylactic reaction due to administration of blood and blood products, initial encounter
        • T80.51XD - Anaphylactic reaction due to administration of blood and blood products, subsequent encounter
        • T80.51XS - Anaphylactic reaction due to administration of blood and blood products, sequela
      • T80.52 - Anaphylactic reaction due to vaccination
        • T80.52XA - Anaphylactic reaction due to vaccination, initial encounter
        • T80.52XD - Anaphylactic reaction due to vaccination, subsequent encounter
        • T80.52XS - Anaphylactic reaction due to vaccination, sequela
      • T80.59 - Anaphylactic reaction due to other serum
        • T80.59XA - Anaphylactic reaction due to other serum, initial encounter
        • T80.59XD - Anaphylactic reaction due to other serum, subsequent encounter
        • T80.59XS - Anaphylactic reaction due to other serum, sequela
    • T80.6 - Other serum reactions
      • T80.61 - Other serum reaction due to administration of blood and blood products
        • T80.61XA - Other serum reaction due to administration of blood and blood products, initial encounter
        • T80.61XD - Other serum reaction due to administration of blood and blood products, subsequent encounter
        • T80.61XS - Other serum reaction due to administration of blood and blood products, sequela
      • T80.62 - Other serum reaction due to vaccination
        • T80.62XA - Other serum reaction due to vaccination, initial encounter
        • T80.62XD - Other serum reaction due to vaccination, subsequent encounter
        • T80.62XS - Other serum reaction due to vaccination, sequela
      • T80.69 - Other serum reaction due to other serum
        • T80.69XA - Other serum reaction due to other serum, initial encounter
        • T80.69XD - Other serum reaction due to other serum, subsequent encounter
        • T80.69XS - Other serum reaction due to other serum, sequela
    • T80.8 - Other complications following infusion, transfusion and therapeutic injection
      • T80.81 - Extravasation of vesicant agent
        • T80.810 - Extravasation of vesicant antineoplastic chemotherapy
          • T80.810A - Extravasation of vesicant antineoplastic chemotherapy, initial encounter
          • T80.810D - Extravasation of vesicant antineoplastic chemotherapy, subsequent encounter
          • T80.810S - Extravasation of vesicant antineoplastic chemotherapy, sequela
        • T80.818 - Extravasation of other vesicant agent
          • T80.818A - Extravasation of other vesicant agent, initial encounter
          • T80.818D - Extravasation of other vesicant agent, subsequent encounter
          • T80.818S - Extravasation of other vesicant agent, sequela
      • T80.82 - Complication of immune effector cellular therapy
        • T80.82XA - Complication of immune effector cellular therapy, initial encounter
        • T80.82XD - Complication of immune effector cellular therapy, subsequent encounter
        • T80.82XS - Complication of immune effector cellular therapy, sequela
      • T80.89 - Other complications following infusion, transfusion and therapeutic injection
        • T80.89XA - Other complications following infusion, transfusion and therapeutic injection, initial encounter
        • T80.89XD - Other complications following infusion, transfusion and therapeutic injection, subsequent encounter
        • T80.89XS - Other complications following infusion, transfusion and therapeutic injection, sequela
    • T80.9 - Unspecified complication following infusion, transfusion and therapeutic injection
      • T80.90 - Unspecified complication following infusion and therapeutic injection
        • T80.90XA - Unspecified complication following infusion and therapeutic injection, initial encounter
        • T80.90XD - Unspecified complication following infusion and therapeutic injection, subsequent encounter
        • T80.90XS - Unspecified complication following infusion and therapeutic injection, sequela
      • T80.91 - Hemolytic transfusion reaction, unspecified incompatibility
        • T80.910 - Acute hemolytic transfusion reaction, unspecified incompatibility
          • T80.910A - Acute hemolytic transfusion reaction, unspecified incompatibility, initial encounter
          • T80.910D - Acute hemolytic transfusion reaction, unspecified incompatibility, subsequent encounter
          • T80.910S - Acute hemolytic transfusion reaction, unspecified incompatibility, sequela
        • T80.911 - Delayed hemolytic transfusion reaction, unspecified incompatibility
          • T80.911A - Delayed hemolytic transfusion reaction, unspecified incompatibility, initial encounter
          • T80.911D - Delayed hemolytic transfusion reaction, unspecified incompatibility, subsequent encounter
          • T80.911S - Delayed hemolytic transfusion reaction, unspecified incompatibility, sequela
        • T80.919 - Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed
          • T80.919A - Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed, initial encounter
          • T80.919D - Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed, subsequent encounter
          • T80.919S - Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed, sequela
      • T80.92 - Unspecified transfusion reaction
        • T80.92XA - Unspecified transfusion reaction, initial encounter
        • T80.92XD - Unspecified transfusion reaction, subsequent encounter
        • T80.92XS - Unspecified transfusion reaction, sequela

Note: The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes are developed and maintained by the Centers for Disease Control and Prevention (CDC). CDC's National Center for Health Statistics (NCHS) is responsible for the clinical modification of ICD-10 for use in the United States. The World Health Organization (WHO), which owns and publishes ICD-10, authorized NCHS to develop ICD-10-CM. All modifications to ICD-10 must conform to WHO's established ICD structure and conventions. All rights are reserved by the respective entities.